In addition, Zheng et al. (2020) demonstrated that glycolytic enzyme Enolase 2 (ENO2) can induce EMT in patients with pancreatic ductal adenocarcinoma (PDAC), thus developing metastasis of PDAC cells [71]. Here, ENO2 is linked to pancreatic ductal adenocarcinoma.